RPL17P37

Across TCGA pan-cancer cohorts, RPL17P37 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RPL17P37 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RPL17P37 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL17P37 expression acts as an unfavorable survival marker, although some lineages such as COAD and PAAD show a favorable association.

COAD, SARC, and READ are the cancer types where RPL17P37 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	II,III,IV	0.892	0.639	.008	45	view →
SARC	DFS	Tertile	All	0.229	0.560	.002	18	view →
READ	OS	Tertile	All	0.743	0.926	.015	15	view →
LIHC	OS	Tertile	All	0.372	0.691	.003	15	view →
BLCA	DFS	Tertile	IV	0.219	0.487	.037	9	view →
PAAD	OS	Tertile	II,III,IV	0.771	0.346	.015	9	view →
UCS	DFS	Tertile	III,IV	0.813	0.356	.043	6	view →
UCEC	DFS	Tertile	All	0.854	0.901	.045	6	view →
ESCA	OS	Median	II,III,IV	0.617	1.000	.049	3	view →
SKCM	OS	Tertile	III,IV	0.808	0.374	.032	3	view →
STAD	DFS	Quartile	IV	0.140	0.640	.046	3	view →
LUAD	DFS	Tertile	All	0.895	0.782	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RPL17P37–COAD (DFS)

Open the COAD breakdown →